Linda van Campen

C. Linda van Campen, aka, C.(Linda)M.C. van Campen, is a Cardiologist and Director at Stichting Cardiozorg, Hoofddorp, The Netherlands.

Open letters

 * 19 June 2018, Linda van Campen signed an open letter to the editor of The Lancet urging the editor to commission a fully independent review of the PACE trial, which the journal published in 2011.
 * 28 August 2019, Trial By Error: an open letter to Dr Godlee about BMJ’s ethically bankrupt actions, by David Tuller

Clinic location

 * Stichting Cardio Zorg, Hoofddorp, The Netherlands

Notable studies

 * 2018, The Abnormal Cardiac Index and Stroke Volume Index Changes During a Normal Tilt Table Test in ME/CFS Patients Compared to Healthy Volunteers, are Not Related to Deconditioning - (Full text)
 * 2018, Blood Volume Status in ME/CFS Correlates With the Presence or Absence of Orthostatic Symptoms: Preliminary Results - (Full text)
 * 2018, Blood Volume Status in Patients with Chronic Fatigue Syndrome: Relation to Complaints - (Full text)
 * 2018, Low Sensitivity of Abbreviated Tilt Table Testing for Diagnosing Postural Tachycardia Syndrome in Adults With ME/CFS - (Full text)
 * 2019, Open Trial of Vitamin B12 Nasal Drops in Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Comparison of Responders and Non-Responders - (Full text)
 * 2020, Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography - (Full text)

Talks and interviews

 * 2017, CFS/ME Research Collaborative Conference, Speech title: Cerebral blood flow decline: deconditioning or disease? - (Video)

Online presence

 * PubMed
 * Twitter
 * Facebook
 * Website
 * YouTube